Bridge Creek Capital Management LLC Bristol Myers Squibb CO Transaction History

Bridge Creek Capital Management LLC

$329 Million
Q3 2024

A detailed history of Bridge Creek Capital Management LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Bridge Creek Capital Management LLC holds 5,651 shares of BMY stock, worth $321,202. This represents 0.09% of its overall portfolio holdings.

Number of Shares

5,651

Previous 6,156 8.2%

Holding current value

$321,202

Previous $255,000 14.51%

% of portfolio

0.09%

Previous 0.08%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 07, 2024	SELL	$39.66 - $51.75 $20,028 - $26,133	-505 Reduced 8.2%	5,651 $292,000
Q1 2024 Apr 11, 2024	BUY	$47.98 - $54.4 $5,805 - $6,582	121 Added 2.0%	6,156 $333,000
Q4 2023 Jan 22, 2024	SELL	$48.48 - $57.85 $2,908 - $3,471	-60 Reduced 0.98%	6,035 $309,000
Q3 2023 Oct 16, 2023	SELL	$57.89 - $64.73 $2,026 - $2,265	-35 Reduced 0.57%	6,095 $353,000
Q1 2023 Apr 13, 2023	BUY	$65.71 - $74.53 $3,285 - $3,726	50 Added 0.82%	6,130 $424,000
Q4 2022 Jan 24, 2023	SELL	$68.48 - $81.09 $7,738 - $9,163	-113 Reduced 1.82%	6,080 $0
Q3 2022 Oct 13, 2022	SELL	$0.13 - $76.84 $0 - $537	-7 Reduced 0.11%	6,193 $440,000
Q2 2022 Jul 19, 2022	SELL	$72.62 - $79.98 $15,976 - $17,595	-220 Reduced 3.43%	6,200 $477,000
Q1 2022 May 12, 2022	SELL	$61.48 - $73.72 $3,504 - $4,202	-57 Reduced 0.88%	6,420 $469,000
Q4 2021 Jan 12, 2022	BUY	$53.63 - $62.52 $4,504 - $5,251	84 Added 1.31%	6,477 $404,000
Q3 2021 Nov 05, 2021	BUY	$59.17 - $69.31 $49,288 - $57,735	833 Added 14.98%	6,393 $378,000
Q2 2021 Jul 30, 2021	SELL	$61.91 - $67.42 $16,715 - $18,203	-270 Reduced 4.63%	5,560 $371,000
Q1 2021 Apr 09, 2021	SELL	$59.34 - $66.74 $2,967 - $3,336	-50 Reduced 0.85%	5,830 $368,000
Q4 2020 Jan 21, 2021	SELL	$57.74 - $65.43 $5,774 - $6,543	-100 Reduced 1.67%	5,880 $365,000
Q3 2020 Oct 16, 2020	SELL	$57.43 - $63.64 $12,175 - $13,491	-212 Reduced 3.42%	5,980 $361,000
Q1 2020 Apr 14, 2020	BUY	$46.4 - $67.43 $6,960 - $10,114	150 Added 2.48%	6,192 $345,000
Q4 2019 Jan 14, 2020	BUY	$49.21 - $64.19 $26,425 - $34,470	537 Added 9.75%	6,042 $388,000
Q3 2019 Oct 10, 2019	SELL	$42.77 - $50.71 $31,008 - $36,764	-725 Reduced 11.64%	5,505 $279,000
Q1 2019 Apr 05, 2019	BUY	$45.12 - $53.8 $22,560 - $26,900	500 Added 8.73%	6,230 $297,000
Q4 2018 Jan 18, 2019	SELL	$48.76 - $63.23 $3,657 - $4,742	-75 Reduced 1.29%	5,730 $298,000
Q2 2018 Jul 20, 2018	SELL	$50.53 - $62.98 $2,526 - $3,149	-50 Reduced 0.85%	5,805 $321,000
Q1 2018 Apr 09, 2018	BUY	$59.92 - $68.98 $2,996 - $3,449	50 Added 0.86%	5,855 $370,000
Q4 2017 Jan 19, 2018	SELL	$59.94 - $65.35 $1,498 - $1,633	-25 Reduced 0.43%	5,805 $0
Q3 2017 Oct 12, 2017	BUY	$55.23 - $63.74 $321,990 - $371,604	5,830	5,830 $372,000

Others Institutions Holding BMY

# of Institutions

2,537

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $121B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridge Creek Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridge Creek Capital Management LLC with notifications on news.

Account

Bridge Creek Capital Management LLC Bristol Myers Squibb CO Transaction History